Floatz logo

Vortioxetine

Negative Symptoms

Northwell HealthSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Negative Symptoms cohort.

Asset / SponsorPhaseRating
Risperdal
National Institute of Mental Health and Neuro Sciences, India
Phase 4BB
CITALOPRAM
National Institute of Mental Health and Neuro Sciences, India
Phase 4BB
BRADANICLINE
Targacept Inc.
Phase 2B
Guarana Extract
Faculdade de Medicina do ABC
Phase 2B
Cytosin-Arabinosid
Institute of Hematology & Blood Diseases Hospital, China
Phase 2CCC

View all 11 →

Same molecule, other indications

Vortioxetine is also rated in:

major depressive disorderDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar depressionDormant
BB
Indicative ·
69 / 100
View asset →
anxiety disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →